CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

JAK2 V617F / CALR / MPL mutation (MPN)

Gene: JAK2/CALR/MPL · Type: mutation

Indications: Myelofibrosis, Polycythemia vera

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
RuxolitinibMyelofibrosis, Polycythemia veraINDICATED
FDA Label
Label
FedratinibMyelofibrosis, Polycythemia veraINDICATED
FDA Label
Label
PacritinibMyelofibrosis, Polycythemia veraINDICATED
FDA Label
Label
MomelotinibMyelofibrosis, Polycythemia veraINDICATED
FDA Label
Label